13 results  1 of 1 

1 A Neonate Diagnosed with Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome with PIK3CA Mutation
Young Mi Park, Yoon-Myung Kim, Seong Hee Oh, Hyun-Seung Jin
Neonatal Med.2023;30(2):55-59.   Published online 2023 May 31     DOI: http://dx.doi.org/10.5385/nm.2023.30.2.55
      
2 PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
Ju Won Kim, Ah Reum Lim, Ji Young You, Jung Hyun Lee, Sung Eun Song, Nam Kwon Lee, Seung Pil Jung, Kyu Ran Cho, Cheol Yong Kim, Kyong Hwa Park
Cancer Res Treat.2023;55(2):531-541.   Published online 2022 September 7     DOI: http://dx.doi.org/10.4143/crt.2022.221
      
3 Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer
Jieun Park, Soo Youn Cho, Eun Sol Chang, Minjung Sung, Ji-Young Song, Kyungsoo Jung, Sung-Su Kim, Young Kee Shin, Yoon-La Choi
Cancer Res Treat.2023;55(1):145-154.   Published online 2022 April 20     DOI: http://dx.doi.org/10.4143/crt.2022.001
      
4 Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand
Arunee Dechaphunkul, Phatcharaporn Thongwatchara, Paramee Thongsuksai, Tanadech Dechaphunkul, Sarayut Lucien Geater
J Pathol Transl Med.2022;56(3):126-133.   Published online 2022 February 28     DOI: http://dx.doi.org/10.4132/jptm.2022.01.04
      
5 Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
Aiko Ogasawara, Taro Hihara, Daisuke Shintani, Akira Yabuno, Yuji Ikeda, Kenji Tai, Keiichi Fujiwara, Keisuke Watanabe, Kosei Hasegawa
Cancer Res Treat.2020;52(4):1219-1228.   Published online 2020 May 6     DOI: http://dx.doi.org/10.4143/crt.2019.688
      
6 PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
Cancer Res Treat.2020;52(3):689-696.   Published online 2020 February 4     DOI: http://dx.doi.org/10.4143/crt.2019.497
      
7 Silencing the PIK3CA Gene Enhances the Sensitivity of Childhood Leukemia Cells to Chemotherapy Drugs by Suppressing the Phosphorylation of Akt
Xiuling Liang, Xianfang Xin, Dongmei Qi, Chengyan Fu, Mingde Ding
Yonsei Med J.2019;60(2):182-190.   Published online 2019 January 17     DOI: http://dx.doi.org/10.3349/ymj.2019.60.2.182
      
8 Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
Ling Deng, Xuehua Zhu, Yun Sun, Jiemin Wang, Xiaorong Zhong, Jiayuan Li, Min Hu, Hong Zheng
Cancer Res Treat.2019;51(1):128-140.   Published online 2018 March 15     DOI: http://dx.doi.org/10.4143/crt.2017.598
      
9 Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer
Min-Young Lee, Bo Mi Ku, Hae Su Kim, Ji Yun Lee, Sung Hee Lim, Jong-Mu Sun, Se-Hoon Lee, Keunchil Park, Young Lyun Oh, Mineui Hong, Han-Sin Jeong, Young-Ik Son, Chung-Hwan Baek, Myung-Ju Ahn
Cancer Res Treat.2017;49(4):906-914.   Published online 2016 December 26     DOI: http://dx.doi.org/10.4143/crt.2016.424
      
10 Clinicopathological Significance of Elevated PIK3CA Expression in Gastric Cancer
Si-Hyong Jang, Kyung-Ju Kim, Mee-Hye Oh, Ji-Hye Lee, Hyun Ju Lee, Hyun Deuk Cho, Sun Wook Han, Myoung Won Son, Moon Soo Lee
J Gastric Cancer.2016;16(2):85-92.   Published online 2016 June 24     DOI: http://dx.doi.org/10.5230/jgc.2016.16.2.85
      
11 A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors
Ji-Youn Han, Ki Hyeong Lee, Sang-We Kim, Young Joo Min, Eunkyung Cho, Youngjoo Lee, Soo-Hyun Lee, Hyae Young Kim, Geon Kook Lee, Byung Ho Nam, Hyesun Han, Jina Jung, Jin Soo Lee
Cancer Res Treat.2017;49(1):10-19.   Published online 2016 May 3     DOI: http://dx.doi.org/10.4143/crt.2016.058
      
12 Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation
Rishi Agarwal, Kimberly Koenig, Eric Rohren, Vivek Subbiah
J Breast Cancer.2014;17(3):287-290.   Published online 2014 September 30     DOI: http://dx.doi.org/10.4048/jbc.2014.17.3.287
      
13 PIK3CA Mutations in Hepatocellular Carcinoma in Korea
Heesue Kim, Cheol-Keun Park, Su Jin Lee, Sun Young Rha, Kyu Hyun Park, Ho Yeong Lim
Yonsei Med J.2013;54(4):883-887.   Published online 2013 May 14     DOI: http://dx.doi.org/10.3349/ymj.2013.54.4.883
      

 1 of 1